1 Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.

2 Targeted brain delivery nanoparticles for malignant gliomas.

3 Lipid Fraction Derived From MRI In- and Opposed-Phase Sequence as a Novel Biomarker for Predicting Survival Outcome of Glioma.

4 Single Port Endoscope-Assisted Excision of Forehead Lesions: An Innovative Way of Improving the Optical Cavity.

5 Improved Delineation of Glioma Margins and Regions of Infiltration with the Use of Diffusion Tensor Imaging: An Image-Guided Biopsy Study

6 Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.

7 Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.

8 Tumor border sharpness correlates with HLA-G expression in low-grade gliomas.

9 FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas.

10 A Novel Deep Learning Algorithm for the Automatic Detection of High-Grade Gliomas on T2-Weighted Magnetic Resonance Images: A Preliminary Machine Learning Study.

11 Outcome Prediction for Patient with High-Grade Gliomas from Brain Functional and Structural Networks.

12 Advanced imaging in adult diffusely infiltrating low-grade gliomas.

13 Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.

14 Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.

15 DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development

16 Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival

17 Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases

18 Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO… and Shakespeare

19 Genome-wide comparison of paired fresh frozen and formalin-fixed paraffin-embedded gliomas by custom BAC and oligonucleotide array comparative genomic hybridization: facilitating analysis of archival gliomas

20 Brainstem angiocentric gliomas with MYB–QKI rearrangements

21 Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas

22 Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited

23 frequency of epstein-barr virus dna sequences in human gliomas

24 the characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats

25 isocitrate dehydrogenase (idh) status prediction in histopathology images of gliomas using deep learning

26 neuroimaging of adult gliomas: an update

27 current approaches to chemoradiotherapy for malignant gliomas

28 combining molecular targeted agents with radiation therapy for malignant gliomas

29 facing contrast-enhancing gliomas: perfusion mri in grade iii and grade iv gliomas according to tumor area

30 recent advances of dendritic cells (dcs)-based immunotherapy for malignant gliomas

31 bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern

32 pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: a monocentric, observational and prospective pilot study

33 temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review

34 multimodality imaging of paragangliomas of the head and neck

35 elevated tert expression in tert-wildtype adult diffuse gliomas: histological evaluation with a novel tert-specific antibody

36 stem cells and the origin of gliomas: a historical reappraisal with molecular advancements

37 epstein–barr virus in gliomas: cause, association, or artifact?

38 analysis of dti-derived tensor metrics in differential diagnosis between low-grade and high-grade gliomas

39 with a little help from my friends: the role of intraoperative fluorescent dyes in the surgical management of high-grade gliomas

40 patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment

41 stereotactic injection of dti-015 into recurrent malignant gliomas: phase i/ii trial

42 quantitative proteomic profiling of tachyplesin i targets in u251 gliomaspheres

43 immunosuppressive mechanisms of malignant gliomas: parallels at non-cns sites

44 phase ii trial of erlotinib during and after radiotherapy in children with newly diagnosed high-grade gliomas

45 genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas

46 aberrant methylation and reduced expression of lhx9 in malignant gliomas of childhood

47 fermented mistletoe extract as a multimodal antitumoral agent in gliomas

48 diagnostic and prognostic significance of methionine uptake and methionine positron emission tomography imaging in gliomas

49 adam 12: a putative marker of oligodendrogliomas?

50 genetically engineered multilineage-differentiating stress-enduring cells as cellular vehicles against malignant gliomas

51 Surgical management of incidentally discovered low-grade gliomas

52 Diagnostic challenges, management and outcomes of midline low-grade gliomas - Journal of Neuro-Oncology

53 P17MANAGEMENT AND OUTCOMES OF MIDLINE LOW-GRADE GLIOMAS

54 Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods

55 A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion.

56 Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.

Keyword Connections

Journals

Research Groups

Bibliographies